19-13303585-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001127222.2(CACNA1A):c.2133C>A(p.Ile711Ile) variant causes a synonymous change. The variant allele was found at a frequency of 0.00000497 in 1,610,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 29)
Exomes 𝑓: 0.0000048 ( 0 hom. )
Consequence
CACNA1A
NM_001127222.2 synonymous
NM_001127222.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.58
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.21).
BS2
High AC in GnomAdExome4 at 7 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.2133C>A | p.Ile711Ile | synonymous_variant | 17/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.2136C>A | p.Ile712Ile | synonymous_variant | 17/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.2139C>A | p.Ile713Ile | synonymous_variant | 17/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.2136C>A | p.Ile712Ile | synonymous_variant | 17/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.2136C>A | p.Ile712Ile | synonymous_variant | 17/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.2136C>A | p.Ile712Ile | synonymous_variant | 17/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.1995C>A | p.Ile665Ile | synonymous_variant | 16/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389.1 | c.2136C>A | p.Ile712Ile | synonymous_variant | 17/47 | 5 | ENSP00000489992.1 | |||
CACNA1A | ENST00000637432.1 | c.2136C>A | p.Ile712Ile | synonymous_variant | 17/48 | 5 | ENSP00000490617.1 | |||
CACNA1A | ENST00000636549.1 | c.2136C>A | p.Ile712Ile | synonymous_variant | 17/48 | 5 | ENSP00000490578.1 | |||
CACNA1A | ENST00000637927.1 | c.2139C>A | p.Ile713Ile | synonymous_variant | 17/47 | 5 | ENSP00000489715.1 | |||
CACNA1A | ENST00000635895.1 | c.2136C>A | p.Ile712Ile | synonymous_variant | 17/47 | 5 | ENSP00000490323.1 | |||
CACNA1A | ENST00000638009.2 | c.2136C>A | p.Ile712Ile | synonymous_variant | 17/47 | 1 | ENSP00000489913.1 | |||
CACNA1A | ENST00000637276.1 | c.2136C>A | p.Ile712Ile | synonymous_variant | 17/46 | 5 | ENSP00000489777.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151874Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
1
AN:
151874
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000480 AC: 7AN: 1459098Hom.: 0 Cov.: 32 AF XY: 0.00000551 AC XY: 4AN XY: 725572
GnomAD4 exome
AF:
AC:
7
AN:
1459098
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
725572
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151874Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 74156
GnomAD4 genome
AF:
AC:
1
AN:
151874
Hom.:
Cov.:
29
AF XY:
AC XY:
0
AN XY:
74156
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 24, 2023 | This sequence change affects codon 712 of the CACNA1A mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the CACNA1A protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CACNA1A-related conditions. ClinVar contains an entry for this variant (Variation ID: 578805). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at